S&P 500   4,109.31
DOW   33,274.15
QQQ   320.93
Closing prices for crude oil, gold and other commodities
What’s At Stake In April is Shocking (Ad)pixel
MarketBeat Week in Review – 3/27 - 3/31
UK travelers face hours-long waits for ferries to France
Stocks are for suckers – try this instead (Ad)
UN body mulls deep sea mining amid demand for minerals
Credit Suisse takeover hits heart of Swiss banking, identity
Stocks are for suckers – try this instead (Ad)
Intensity and insults rise as lawmakers debate debt ceiling
Canada approves largest telecom deal in country's history
S&P 500   4,109.31
DOW   33,274.15
QQQ   320.93
Closing prices for crude oil, gold and other commodities
What’s At Stake In April is Shocking (Ad)pixel
MarketBeat Week in Review – 3/27 - 3/31
UK travelers face hours-long waits for ferries to France
Stocks are for suckers – try this instead (Ad)
UN body mulls deep sea mining amid demand for minerals
Credit Suisse takeover hits heart of Swiss banking, identity
Stocks are for suckers – try this instead (Ad)
Intensity and insults rise as lawmakers debate debt ceiling
Canada approves largest telecom deal in country's history
S&P 500   4,109.31
DOW   33,274.15
QQQ   320.93
Closing prices for crude oil, gold and other commodities
What’s At Stake In April is Shocking (Ad)pixel
MarketBeat Week in Review – 3/27 - 3/31
UK travelers face hours-long waits for ferries to France
Stocks are for suckers – try this instead (Ad)
UN body mulls deep sea mining amid demand for minerals
Credit Suisse takeover hits heart of Swiss banking, identity
Stocks are for suckers – try this instead (Ad)
Intensity and insults rise as lawmakers debate debt ceiling
Canada approves largest telecom deal in country's history
S&P 500   4,109.31
DOW   33,274.15
QQQ   320.93
Closing prices for crude oil, gold and other commodities
What’s At Stake In April is Shocking (Ad)pixel
MarketBeat Week in Review – 3/27 - 3/31
UK travelers face hours-long waits for ferries to France
Stocks are for suckers – try this instead (Ad)
UN body mulls deep sea mining amid demand for minerals
Credit Suisse takeover hits heart of Swiss banking, identity
Stocks are for suckers – try this instead (Ad)
Intensity and insults rise as lawmakers debate debt ceiling
Canada approves largest telecom deal in country's history
NYSE:MYOV

Myovant Sciences - MYOV Insider Trading & Ownership

$26.98
-0.01 (-0.04%)
(As of 03/9/2023)
Add
Compare
Today's Range
$26.98
▼
$27.00
50-Day Range
$26.87
▼
$26.99
52-Week Range
$7.67
▼
$27.06
Volume
2.26 million shs
Average Volume
1.17 million shs
Market Capitalization
$2.62 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$21.33

Myovant Sciences (NYSE:MYOV) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
1.90%
Number Of
Insiders Buying
(Last 12 Months)
1
Amount Of
Insider Buying
(Last 12 Months)
$1.39 B
Number Of
Insiders Selling
(Last 12 Months)
4
Amount Of
Insider Selling
(Last 12 Months)
$1.60 M

MYOV Insider Buying and Selling by Quarter

Get MYOV Insider Trade Alerts

Want to know when executives and insiders are buying or selling Myovant Sciences stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

Myovant Sciences Insider Trades History

Export to Excel
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
3/10/2023Chemical Co. Ltd. SumitomoMajor ShareholderBuy51,599,200$27.00$1,393,178,400.0045,798,176  
1/18/2023Lauren MerendinoInsiderSell2,008$26.89$53,995.12169,538  
1/18/2023Matthew LangGeneral CounselSell1,272$26.89$34,204.08354,303  
1/4/2023Ferreira Juan Camilo ArjonaInsiderSell2,251$26.90$60,551.90247,793  
1/4/2023Matthew LangGeneral CounselSell2,779$26.90$74,755.10355,575  
12/16/2022Uneek MehraInsiderSell2,241$26.75$59,946.75202,696  
10/18/2022Lauren MerendinoInsiderSell1,703$25.20$42,915.60171,546  
10/18/2022Matthew LangGeneral CounselSell1,933$25.20$48,711.60358,354  
10/4/2022Ferreira Juan Camilo ArjonaInsiderSell2,738$24.40$66,807.20251,648  
10/4/2022Matthew LangGeneral CounselSell3,679$24.40$89,767.60360,287  
9/16/2022Uneek MehraInsiderSell9,243$18.86$174,322.98204,937  
8/15/2022Matthew LangGeneral CounselSell31,214$18.23$569,031.22363,966  
7/18/2022Lauren MerendinoInsiderSell1,704$12.87$21,930.48173,249  
7/18/2022Matthew LangGeneral CounselSell1,935$12.87$24,903.45270,400  
7/6/2022Ferreira Juan Camilo ArjonaInsiderSell2,755$13.40$36,917.00255,992  
7/6/2022Matthew LangGeneral CounselSell3,702$13.40$49,606.80272,335  
4/19/2022Ferreira Juan Camilo ArjonaInsiderSell4,632$10.45$48,404.40260,129  
4/19/2022Matthew LangGeneral CounselSell8,002$10.45$83,620.90276,037  
4/5/2022Ferreira Juan Camilo ArjonaInsiderSell1,922$13.78$26,485.16  
4/5/2022Matthew LangGeneral CounselSell2,436$13.78$33,568.08  
(Data available from 1/1/2013 forward)












MYOV Insider Trading Activity - Frequently Asked Questions

Who is on Myovant Sciences's Insider Roster?

The list of insiders at Myovant Sciences includes Chemical Co. Ltd. Sumitomo, David C Marek, Ferreira Juan Camilo Arjona, Frank Karbe, Lauren Merendino, Matthew Lang, and Uneek Mehra. Learn more on insiders at MYOV.

What percentage of Myovant Sciences stock is owned by insiders?

1.90% of Myovant Sciences stock is owned by insiders. Learn more on MYOV's insider holdings.

Which Myovant Sciences insiders have been buying company stock?

The following insider purchased MYOV shares in the last 24 months: Chemical Co. Ltd. Sumitomo ($1,411,896,492.80).

How much insider buying is happening at Myovant Sciences?

Insiders have purchased a total of 52,413,801 MYOV shares in the last 24 months for a total of $1,411,896,492.80 bought.

Which Myovant Sciences insiders have been selling company stock?

The following insiders have sold MYOV shares in the last 24 months: David C Marek ($291,867.76), Ferreira Juan Camilo Arjona ($1,552,569.36), Frank Karbe ($206,420.40), Lauren Merendino ($118,841.20), Matthew Lang ($1,577,104.62), and Uneek Mehra ($234,269.73).

How much insider selling is happening at Myovant Sciences?

Insiders have sold a total of 204,298 Myovant Sciences shares in the last 24 months for a total of $3,981,073.07 sold.

This page (NYSE:MYOV) was last updated on 4/1/2023 by MarketBeat.com Staff